Vincerx Pharma, Inc. (VINC) Stock Forecast
VINC analyst forecast
as of October 21, 2026- Analyst consensus
- Strong buy 4.50 / 5 from 2 analysts
- Price target
- $200.00 average of analyst targets
- Upside to target
- +1,333,233.3% from the latest close
- Next earnings
- —
- 52-week range
- $0.01 – $0.03
VINC analyst ratings
2 analystsNumber of analysts at each rating.
VINC price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
VINC earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | — | — | — |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
VINC revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Next fiscal year (2026) | $0 | $0 | $0 | — | — |
VINC EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
VINC EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Next fiscal year (2026) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
VINC earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; VINC beat in 2 of 12.
What analysts expect from VINC
2 analysts cover Vincerx Pharma; their consensus rating is strong buy (4.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $200.00, 1,333,233.3% above the latest close of $0.01. For 2026 the average estimate is $0.00 per share. Vincerx Pharma beat the EPS estimate in 2 of the last 12 quarters.
Related: VINC income statement, VINC key metrics, VINC chart. See the VINC stock overview for the latest quote and news.
VINC forecast FAQ
What is Vincerx Pharma's price target?
The average analyst price target for Vincerx Pharma is $200.00, 1,333,233.3% above the latest close of $0.01.
Is Vincerx Pharma a buy, hold or sell?
Of 2 analysts covering Vincerx Pharma, 1 rate it a strong buy, 1 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
Does Vincerx Pharma usually beat earnings estimates?
Vincerx Pharma reported EPS at or above the analyst estimate in 2 of the last 12 quarters.